Immune-Mediated Damage and Repair

A03

Interplay between pro-inflammatory cytokines and chromatin-remodeling enzymes in the regulation of central nervous system demyelination and repair

Univ.-Prof. Dr. rer. nat. Ari Waisman
Institut für Molekulare Medizin
Mainz

Prof. Dr. rer. nat. Claire Jacob
Institut für Entwicklungsbiologie und Neurobiologie
Mainz

 

B05

Topological patterns of damage and compensation in chronic neuroinflammation

Prof. Dr. med. Sergiu Groppa
Klinik für Neurologie
Mainz

Prof. Dr.-Ing. Muthuraman Muthuraman
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf

 

B06

The role of thr kallikrein-kinin system to functional and structural impairment if network activity in multiple sclerosis

Prof. Dr. rer. nat. Thomas Budde
Institut für Physiologie I
Münster

Dr. med. Kerstin Göbel
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf

 

B07

Linking cholesterol metabolism in myeloid cells to remyelination in mice and humans

Univ.-Prof. Dr. med. Tanja Kuhlmann
Institut für Neuropathologie
Münster

Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München

 

B09

Rebalancing cortical neuronal hyperactivity as a new treatment strategy in neuroinflammation

Dr. med. Erik Ellwardt
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Albrecht Stroh
Institut für Mikroskopische Anatomie und Neurobiologie
Mainz

 

B10

Molecular dissection of autoimmune lesion induction and resolution in the central nervous system

Univ.-Prof. Dr. med. Martin Kerschensteiner
Institut für Klinische Neuroimmunologie
LMU München

Priv.-Doz. Dr. rer. nat. Naoto Kawakami
Institut für Klinische Neuroimmunologie
LMU München

 

B12

Balancing glutamate and cation channel signaling in inflammatory neuronal injury

Prof. Dr. med. Stefan Bittner
Klinik für Neurologie
Mainz

 

B13

Disturbed iron metabolism in phagocytes as a driver of chronic inflammation – a model of MS progression?

Univ.-Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München

Univ.-Prof. Dr. med. Martin Kerschensteiner
Institut für Klinische Neuroimmunologie
LMU München

 

B14

NfL and EGFL7 as biomarkers for neuroaxoonal damage and BBB-integrity in neuroinflammation: a translational approach

Dr. med. Timo Uphaus
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Frauke Zipp
Klinik für Neurologie, Forschungszentrum Immuntherapie
Mainz

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more